OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production within Chinese hamster ovary (CHO) cells is a paramount challenge with the biopharmaceutical industry. Multiple strategies are employed maximize antibody titer, such as process parameter optimization, media optimization, and implementation of perfusion systems. Fine-tuning media composition play